×

01/01

Tonghua Dongbao has been persistent in continuous product innovation. The constant optimization of the product mix for diabetes treatment has enabled us to keep strengthening our market competitiveness and lead the domestic industry.

About Us

Tonghua Dongbao developed China's first recombinant human insulin, with a trade name of Gansulin, in 1998. As the first of its kind in China, Gansulin helped China overcome years of dependence on imports of the medicine. This achievement won the second prize of the National Science and Technology Progress Award and was listed in the "Top 10 Scientific Breakthroughs 1998". Let’s get a glimpse into Tonghua Dongbao from the following figures.

  • 1985

    Year of founding

  • RMB 3.3bn

    Production Output (2020)

  • 388+

    Number of R&D staff

  • 17+

    Categories of popular products

无码制服丝袜人妻ol在线视频,国产免费午夜福利蜜芽无码,华人少妇被黑人粗大的猛烈进,翁公和在厨房猛烈进出